Related Experiment Video
Updated: May 2, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
[A case of colchicine-responsive Mollaret's meningitis with MEFV gene mutation]
Tomomi Kinohshita1, Akira Matsushima, Shunichi Satoh
1Department of Neurology, Nagano Red-cross Hospital.
Abstract:
A 66-year-old woman was admitted to our hospital with recurrent meningitis. She presented with 10 episodes of meningitis in 10 months. Examination of cerebrospinal fluid demonstrated pleocytosis, with neutrophils dominant at the early stage, and lymphocytes dominant at the late stage. Mollaret cells were found and the level of IL-6 was increased in cerebrospinal fluid. Several antibiotics and antiviral agents failed to prevent relapse. However, colchicine therapy successfully prevented the recurrence of meningitis. Genetic testing for familial Mediterranean fever (FMF) showed a mutation in the MEFV gene. It is difficult to diagnose the cause of Mollaret's meningitis in some patients. FMF, neuro-Behçet's disease, and neuro-Sweet disease should be included in the differential diagnosis of recurrent meningitis. In addition, colchicine therapy can prevent the relapse of meningitis in such cases.
Insights
Familial Mediterranean Fever (FMF) can cause recurrent meningitis. Colchicine therapy effectively prevented meningitis relapses in a patient with an MEFV gene mutation, suggesting its therapeutic potential.
Area of Science:
- Neurology
- Immunology
- Genetics
Background:
- Recurrent meningitis presents a diagnostic challenge, often unresponsive to standard treatments.
- Mollaret's meningitis is characterized by recurrent aseptic meningitis with specific cerebrospinal fluid findings.
Observation:
- A 66-year-old woman experienced 10 episodes of meningitis over 10 months.
- Cerebrospinal fluid analysis revealed pleocytosis, Mollaret cells, and elevated IL-6 levels.
- Initial antibiotic and antiviral treatments were unsuccessful in preventing relapse.
Findings:
- Genetic testing identified a mutation in the MEFV gene, confirming Familial Mediterranean Fever (FMF).
- Colchicine therapy demonstrated complete efficacy in preventing further meningitis recurrence.
- The patient's presentation highlights the link between FMF and recurrent meningitis.
Implications:
- Familial Mediterranean Fever (FMF) should be considered in the differential diagnosis of recurrent meningitis, particularly with Mollaret cells.
- Neuro-Behçet's disease and neuro-Sweet disease are also important considerations for recurrent meningitis.
- Colchicine therapy offers a promising treatment strategy for meningitis relapses associated with FMF.
Related Concept Videos
Bacterial Meningitis II: Pathophysiology
Bacterial Meningitis I: Introduction
Viral Meningitis
Mutations in Microorganisms
Cytomegalovirus Disease
Mismatch Repair
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

